Aurobindo Pharma arm’s biosimilar gets Health Canada NOC
A notice of compliance from Health Canada is issued to a drug manufacturer after a successful review, confirming the product meets regulatory standards for safety, efficacy and quality under the Food and Drug Regulations
What's Your Reaction?